There's Neuralink—and There's the Mind-Reading Company That Might Surpass It

The article discusses Synchron, a company that is developing a brain-computer interface (BCI) that may surpass Elon Musk's Neuralink. Synchron's BCI does not require open-skull surgery, unlike Neuralink's approach. Additionally, Synchron's BCI includes an OpenAI chatbot, providing users with a more advanced interface. The article highlights that Synchron's technology is less invasive, as it is implanted through the blood vessels in the brain, rather than requiring a direct surgical implantation. This makes the procedure less risky and potentially more accessible to a wider range of patients. The article also notes that Synchron's BCI has already been tested in human trials, with promising results, and the company is working towards obtaining regulatory approval for broader use. In contrast, Neuralink has faced challenges in moving from animal trials to human trials. Overall, the article suggests that Synchron's BCI technology may offer a more practical and user-friendly alternative to Neuralink, potentially surpassing it in the race to develop advanced brain-computer interfaces.